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We read with interest the recent article by Dr Chawla and
colleagues showing that a furosemide stress test was able to
predict the development of renal damage stage III accord-
ing to the Acute Kidney Injury Network classification in
critically ill patients [1]. In this study, 25 patients that sub-
sequently developed acute kidney injury (AKI) had lower
urine output 2 hours following administration of furosem-
ide compared with 52 patients that did not develop AKI.
Apart from predicting which patients will develop AKI
based on the renal response to furosemide, this concept
may possibly also be used to predict successful recovery of
renal function after continuous renal replacement therapy
(CRRT) in critically ill patients recovering from AKI.
The current practice to discontinue CRRT mostly con-
siders increases in urine output or a fall in serum creatinine
while on a constant dose of continuous renal support. Ob-
servational studies have shown that the most significant
predictor for successful termination of CRRT is indeed urin-
ary production [2]. Urinary output >400 ml/day has an area
under the receiver operator curve (AUROC) of 0.81, result-
ing in correct classification for 79% of the patients [3]. Not
surprisingly, this predictive ability was negatively influenced
by the use of diuretics; however, the renal response on di-
uretics by itself was not considered a potential predictor.
Previously, we demonstrated that administration of fur-
osemide compared with placebo after termination of CRRT
did not improve renal function or shorten renal failure [4].
In our study, urinary production was measured over a 4-
hour episode after termination of CRRT without any treat-
ment, and was measured again 24 hours later following
either continuous furosemide or placebo administration.
Eighteen of the 71 included patients showed immediate re-
covery of renal function in this 4-hour episode, defined as a
calculated endogenous creatinine clearance >30 ml/minute,
and did not require continuation of CRRT. These 18 pa-
tients had a significantly higher urinary production (median
(interquartile range)) than the others: 103 (78 to 208) ml
versus 47 (17 to 85) ml, P= 0.002. The urinary production
in the 4-hour period without study medication was associ-
ated with renal recovery during the hospital stay (7 (2 to 43)
ml vs. 76 (45 to 130) ml, P = 0.001) with an AUROC of 0.79.
After this 4-hour period, 25 patients received furosemide
0.5 mg/kg/hour intravenously and 24 hours later a 4-hour
urine portion was again collected. This second portion also
showed a significantly higher urine production (654 (333
to 1,155) ml) in those patients in whom renal recovery oc-
curred eventually during their hospital stay compared with
those who did not recover (48 (15 to 207) ml, P = 0.007),
resulting in an AUROC of 0.84.
In summary, we confirm that the spontaneous diuretic
response after CRRT predicts the necessity for continued
CRRT and in-hospital renal recovery. Moreover, the
furosemide-induced diuretic response in patients without
immediate recovery of renal function within 24 hours after
cessation of CRRT is of additional value to predict eventual
renal recovery during their hospital stay.
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Authors' response
Lakhmir S Chawla
We were delighted to read the report by van der Voort
and colleagues [4]. In our study assessing the furosemide
stress test, we hypothesized that the tubular handling of
furosemide makes it an ideal agent to test renal tubular
integrity and reserve [1]. As an organic acid, furosemide
is tightly bound to serum proteins and gains access to
the tubular lumen – not through filtration, but by active
secretion via the human organic anion transporter system
in the proximal convoluted tubule [5,6]. Once in the tubu-
lar lumen, furosemide inhibits luminal active chloride
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transport throughout the thick ascending limb of Henle
[7]. To prevent sodium reabsorption and to increase urine
flow, furosemide thus requires two distinct tubular neph-
ron segments to be functioning – making it the perfect
physiologic and clinical tool for tubular interrogation. Fur-
osemide is therefore well suited to distinguishing progres-
sion in the setting of early AKI as well as renal recovery in
the setting of previously established AKI.
We demonstrated excellent clinical performance in de-
tecting progressive AKI with an AUROC of 0.87. In their
work, van der Voort and colleagues demonstrated simi-
lar performance of the furosemide stress test with an
AUROC of 0.84 for assessing renal recovery [4]. While
the authors did not show the performance of specific
cutoff values of urine output for the 4-hour collection
after a 24-hour infusion of furosemide, they did provide
interquartile ranges for each group. A cutoff value of
about 300 ml appears to produce a test with very good
prognostic performance for the prediction of renal re-
covery. This serves as a proof of concept that the fur-
osemide stress test has potential utility across the AKI
spectrum.
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